cycloheximide has been researched along with Gastrointestinal Stromal Tumors in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akimori, T; Araki, K; Hokimoto, N; Jin, T; Kitagawa, H; Kobayashi, M; Nakano, T; Nakatani, H; Namikawa, T; Okabayashi, T; Okamoto, K; Sugimoto, T; Taguchi, T | 1 |
1 other study(ies) available for cycloheximide and Gastrointestinal Stromal Tumors
| Article | Year |
|---|---|
STI571 (Glivec) induces cell death in the gastrointestinal stromal tumor cell line, GIST-T1, via endoplasmic reticulum stress response.
Topics: Antineoplastic Agents; Benzamides; Blotting, Western; Brefeldin A; Caspase 3; Caspase 7; Caspases; Cell Line, Tumor; Cell Survival; Cycloheximide; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Flow Cytometry; Gastrointestinal Stromal Tumors; Heat-Shock Proteins; Humans; Imatinib Mesylate; Molecular Chaperones; Piperazines; Protein Synthesis Inhibitors; Pyrimidines; Tunicamycin | 2006 |